Locations:
Search IconSearch

Supportive Evidence Mounts for Use of Mobile Stroke Units

New article reviews time-to-treatment data and looks ahead to emerging outcomes and cost studies

650×450-Mobile-Stroke

The future of mobile stroke units (MSUs) is bright, argue three Cleveland Clinic stroke neurologists in an article in the February 2018 issue of Endovascular Today.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“The improvement to time to treatment [with MSUs] is now well established in multiple data sets from around the world,” write M. Shazam Hussain, MD; Ken Uchino, MD; and Andrew Russman, DO, all with Cleveland Clinic’s Cerebrovascular Center.

One of those data sets is from Cleveland Clinic, which in July 2014 deployed one of the very first MSUs in the U.S. and has since reported significant reductions in time to treatment for patients with acute ischemic stroke managed in the Cleveland Clinic MSU compared with those managed in traditional emergency department settings.

The team’s Endovascular Today piece briefly reviews those results and similar findings from the earliest published experience with MSUs, which came from programs in Germany.

“The MSU concept is gaining traction in the United States and around the world,” Drs. Hussain, Uchino and Russman note, “with at least 15 active programs and many others in development.”

The authors also touch on the growing use of CT angiography by MSUs and on MSUs’ increasing role for field triage of patients with emergent large vessel occlusions for intra-arterial revascularization therapy.

They conclude with a look at the emerging wave of initial clinical outcomes data for patients managed on MSUs and a consideration of the nuanced cost-effectiveness issues around MSUs. “The incorporation of telemedicine may further improve cost-effectiveness [of MSUs],” they write, “as one physician can cover many MSUs as well as other duties rather than being committed to travelling with the ambulance.”

Advertisement

The Endovascular Today article is available here.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450

What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast

Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research

Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage

Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board

As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain

Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast

Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis

Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad